Study Comparing Comprehensive Hybrid Cardiac Rehabilitation to Supervised Exercise in Adults with Heart Failure
Led by Universidad de La Frontera · Updated on 2024-12-03
152
Participants Needed
4
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a comprehensive and hybrid cardiac rehabilitation program for patients with heart failure classified as New York Heart Association NYHA class II or III. This study aims to compare the hybrid rehabilitation model with supervised exercise alone, focusing on improving cardiorespiratory fitness, functional capacity, and quality of life. The trial is designed as a randomized clinical superiority study conducted across multiple centers with blinded outcome assessment.
The study involves two groups one receiving a 24-week comprehensive cardiac rehabilitation intervention that includes medical and nurse management, aerobic interval training, resistance exercise, psychosocial support, and education. These services start in a health center and gradually transition to home-based care in four stages. The comparison group will receive face-to-face continuous aerobic exercise and resistance exercises at a center. Both groups receive tailored exercise programs prescribed and monitored by physical therapists.
Participants will be assessed at the beginning, at the end of the 24-week intervention, and again at 12 months. Measures include cardiorespiratory fitness, functional capacity, health-related quality of life, muscle strength, and biomarkers like Pro-B-type Natriuretic Peptide. Researchers will also monitor program adherence, hospital admissions, mortality, and costs. The study requires patients to attend sessions regularly in the initial months and uses mobile devices for communication and support during later stages.
CONDITIONS
Brief Title
Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure
Research Team
F
Francisca Contreras
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Adult patients with heart failure classified as New York Heart Association functional class II or III
Meets heart failure diagnostic criteria according to guidelines
On optimal tolerated medical therapy
Stable condition for at least 1 month as deemed by the treating physician
Able to attend the health center three times a week for the first month and twice a week for months two and three
Owns a mobile phone
Provides informed consent by signing a consent form
You will not qualify if you...
Chronic kidney disease with glomerular filtration rate less than 20 mL/min
Decompensated thyroid disease
End-stage liver failure or Child-Pugh C classification
Cardiac device implantation or cardiac surgery in the previous month or planned in the next 3 months
Dyspnea primarily from non-cardiac causes such as COPD
Atrial fibrillation with resting heart rate greater than 90 beats per minute
Active cancer with life expectancy less than 2 years
Participation in another interventional study
Contraindications to exercise
Comorbidities preventing participation in cardiac rehabilitation
Musculoskeletal or neurological diseases preventing exercise performance
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 24 weeks
Participants receive a 24-week cardiac rehabilitation program including evaluation, medical and nurse management, aerobic interval training, resistance exercise, psychosocial support, and education. The program starts with sessions at a health center and transitions to home-based stages.
3 visits per week during the first month, then 2 visits per week for months two and three; home-based activities thereafter
Follow-up
Duration - Up to 12 months
Participants are followed for health outcomes including cardiorespiratory fitness, functional capacity, and quality of life up to 12 months after starting the intervention.
Visits at 6 months and 12 months after baseline
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Using Your Own Heart Tissue to Support Repair During Coronary Artery Bypass Surgery
AAMS2 Trial on Atrial Appendage Micrograft Transplants for Ischemic Heart Disease
Testing Safety and Feasibility of Patient-Derived Stem Cells for Treating Congenital Heart Disease in Adults Aged 18 to 40
Study of Baduanjin Eight-Silken-Movement Exercise Program Combined With Usual Medication for Adults With Chronic Heart Failure in Guangzhou, China
Evaluating Baroreflex Activation Therapy Using the Barostim System Compared to Usual Care in Adults with Heart Failure
Study Comparing Comprehensive Hybrid Cardiac Rehabilitation to Supervised Exercise in Adults with Heart Failure
Study of SmartSignalHF Device Versus Standard Remote Monitoring for Adults With Heart Failure and Implanted Cardiac Devices
Improving Care for Adults with Heart Failure Using BaroStim and CardioMems Devices
Evaluation of the Cordella Pulmonary Artery Sensor System for Safety and Effectiveness in Adults with NYHA Class II and III Heart Failure
Testing a 12-Week Positive Psychology and Motivational Interviewing Program to Improve Health in Adults with Class I-III Heart Failure
Comparing the Cordella Pulmonary Artery Sensor System to Standard Medication in Adults with Chronic Heart Failure over Two Years
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
CO-CREATION-HF protocol: clinical trial to evaluate the impact of a comprehensive and hybrid cardiac rehabilitation model on patients with heart failure.